Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP473547.RABNmJ6FUWFwZOrHZideVyMHmVYBSKLFqRYCPe7qC5tC8130_assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP473547.RABNmJ6FUWFwZOrHZideVyMHmVYBSKLFqRYCPe7qC5tC8130_provenance.
• NP473538.RAck4e65GmyW4amCIxJcSRPh1zydRkKYS7rmgNuBtpgq0130_assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP473538.RAck4e65GmyW4amCIxJcSRPh1zydRkKYS7rmgNuBtpgq0130_provenance.
• NP686575.RAzhL41FCT-Jd0RUARGk9ts4a1e_YF1_W_Jl30mmOqgd0130_assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686575.RAzhL41FCT-Jd0RUARGk9ts4a1e_YF1_W_Jl30mmOqgd0130_provenance.
• NP686796.RAynBV8A5FkF_CdcO7yiC9CcrpBqsxzF2hhDuqkX1_hek130_assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686796.RAynBV8A5FkF_CdcO7yiC9CcrpBqsxzF2hhDuqkX1_hek130_provenance.
• NP270701.RA8V875fLTGlggWmTBqTjiyySvgCqzlQQWjYLjn_hUqfo130_assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270701.RA8V875fLTGlggWmTBqTjiyySvgCqzlQQWjYLjn_hUqfo130_provenance.
• assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP270707.RAXaCygrBx0u3zmrrd_r26e-aYj8vXvINiw0jYMynk41o130_assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270707.RAXaCygrBx0u3zmrrd_r26e-aYj8vXvINiw0jYMynk41o130_provenance.
• assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP686574.RAsR7wGna9KvCrA6YEDocUY6JD0d6yr8WkfkdcegpOZFU130_assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686574.RAsR7wGna9KvCrA6YEDocUY6JD0d6yr8WkfkdcegpOZFU130_provenance.
• NP686795.RAqiTvBi8BJ3t0On6zuZpsWP_yMgyxIHN0USyQ-eGmEiQ130_assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686795.RAqiTvBi8BJ3t0On6zuZpsWP_yMgyxIHN0USyQ-eGmEiQ130_provenance.
• NP270702.RAMLgnv9ikI2gnKI1ednMVaAw7deZGJyE7aB0Jcp1JTcc130_assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270702.RAMLgnv9ikI2gnKI1ednMVaAw7deZGJyE7aB0Jcp1JTcc130_provenance.
• NP270704.RAIi7WfohqqbBh3X9toLDTxRuJHmsn1OGB9dnrNxS7Nuk130_assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270704.RAIi7WfohqqbBh3X9toLDTxRuJHmsn1OGB9dnrNxS7Nuk130_provenance.
• NP270705.RAqAb_sV5erXz-6vdWF3kIC3f8b4vgf8FJWnjqPN9jFZI130_assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270705.RAqAb_sV5erXz-6vdWF3kIC3f8b4vgf8FJWnjqPN9jFZI130_provenance.
• NP270706.RAu-yn_CUd6cCQ0hJB4B84xZhGkuUJwzyL2OVVnSq4rI4130_assertion description "[Consequently, significantly more ATL cells from patients with lymphoid organ involvement than control CD4(+)CD45RO(+) T cells and ATL cells from patients without lymphoid organ involvement adhered to surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270706.RAu-yn_CUd6cCQ0hJB4B84xZhGkuUJwzyL2OVVnSq4rI4130_provenance.